Daily as of 3 Nov 16:00 ET
- Price
- above both $5.96 vs 50 $5.33 / 200 $4.66
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Sep 2026 · projected 23 bars out
CTKB | Cytek BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$5.96
+$0.19 (+3.29%)
Cytek Biosciences (CTKB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2022.
The 50 SMA has sat above the 200 on the daily since Sep 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $6.13 vs 50 $4.73 / 200 $6.00
- Projection
- 🟨Golden cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- No cross on record
4-hour as of 3 Nov 13:30 ET
- Price
- above both $6.03 vs 50 $5.63 / 200 $4.87
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 16 Jul 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Sep 2026 | 🟨Golden flat | daily | 23 bars out | Not tested |
| 16 Jul 2026 | 🟨Golden | 4-hour | 27 bars out | Not tested |
| 12 May 2026 | 💀Death flat | daily | 1 bar out | Not tested |
| 25 Feb 2026 | 💀Death | 4-hour | 28 bars out | 1 bar cross test |
| 5 Nov 2025 | 🟨Golden flat | daily | 3 bars out | 1 bar cross test |
About CTKB
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.5M
4-hour coverageYes, since Oct 2025
History on recordSince 2022
SectorHealthcare
Cap bandsmall